Latest On Getinge AB (GNGBF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2024-04-23 06:03 EST | Dividend | A dividend of $4.4 has been announced on Feb 1, 2024. It will be paid Apr 29, 2024 with an ex-dividend date of Apr 23, 2024. | Neutral |  |
| 2023-04-27 06:02 EST | Dividend | A dividend of $4.25 has been announced on Feb 2, 2023. It will be paid May 4, 2023 with an ex-dividend date of Apr 27, 2023. | Neutral | |
| 2023-04-27 01:08 EST | News | Getinge AB (publ) (GNGBF) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-04-26 13:04 EST | News | Getinge AB (publ) 2023 Q1 - Results - Earnings Call Presentation | N/A | |
| 2023-04-26 13:04 EST | News | Getinge AB (publ) Non-GAAP EPS of SEK2.34, revenue of SEK7.14B | N/A | |
| 2023-02-02 00:36 EST | News | Getinge AB (publ) (GNGBF) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-01 11:41 EST | News | Getinge AB (publ) 2022 Q4 - Results - Earnings Call Presentation | N/A | |
| 2023-01-26 15:44 EST | News | FDA classifies Getinge's heart devices recall as most serious type | N/A | |
| 2022-10-19 19:11 EST | News | Getinge AB (publ) 2022 Q3 - Results - Earnings Call Presentation | N/A | |
| 2022-10-19 19:11 EST | News | Getinge AB (publ) Non-GAAP EPS of SEK3.10, revenue of SEK6.3B beats by SEK5.47B | N/A | |
| 2022-10-19 19:11 EST | News | Getinge AB (GNGBF) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-07-20 01:51 EST | News | Getinge AB (GNGBF) CEO Mattias Perjos on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-03 06:48 EST | News | Getinge AB (publ) 2022 Q1 - Results - Earnings Call Presentation | N/A | |
| 2022-04-27 06:02 EST | Dividend | A dividend of $4 has been announced on Jan 28, 2022. It will be paid May 3, 2022 with an ex-dividend date of Apr 27, 2022. | Neutral | |
| 2022-04-27 00:46 EST | News | Getinge AB (GNGBF) CEO Mattias Perjos on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-04-26 06:23 EST | News | Getinge AB (publ) Non-GAAP EPS of SEK 2.11, revenue of SEK 6.18B | N/A | |
| 2022-01-28 17:56 EST | News | Getinge AB GAAP EPS of SEK4.54, revenue of SEK7.89B; issues FY22 revenue guidance | N/A | |
| 2022-01-28 17:56 EST | News | Getinge AB 2022 Q4 - Results - Earnings Call Presentation | N/A | |
| 2021-10-20 20:46 EST | News | Getinge AB 2021 Q3 - Results - Earnings Call Presentation | N/A | |
| 2021-10-20 20:46 EST | News | Getinge AB's (GNGBF) CEO Mattias Perjos on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-07-22 14:08 EST | News | Getinge AB 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2021-07-22 14:08 EST | News | Getinge's (GNGBF) CEO Mattias Perjos on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-04-21 11:10 EST | News | Getinge's (GNGBF) CEO Mattias Perjos on Q1 2021 Results - Earnings Call Transcript | N/A | |
| 2021-04-21 06:09 EST | Dividend | A dividend of $3 has been announced on Jan 28, 2021. It will be paid Apr 27, 2021 with an ex-dividend date of Apr 21, 2021. | Neutral | |
| 2021-04-20 16:43 EST | News | Getinge AB 2021 Q1 - Results - Earnings Call Presentation | N/A | |
| 2021-01-30 01:37 EST | Financials | Company financials have been released. | Neutral | |
| 2021-01-28 17:38 EST | News | Getinge AB reports FY results | N/A | |
| 2021-01-28 17:38 EST | News | Getinge AB (GNGBF) CEO Mattias Perjos on Q4 2020 Results - Earnings Call Transcript. | N/A | |
| 2021-01-28 17:38 EST | News | Getinge AB 2020 Q4 - Results - Earnings Call Presentation | N/A | |
| 2020-11-26 23:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 02:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-02 19:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-17 11:22 EST | News | Getinge AB (GNGBF) CEO Mattias Perjos on Q3 2020 Results - Earnings Call Transcript. | N/A | |
| 2020-10-17 11:22 EST | News | Getinge AB 2020 Q3 - Results - Earnings Call Presentation | N/A | |
| 2020-10-16 09:12 EST | News | Getinge AB (GNGBF) CEO Mattias Perjos on Q3 2020 Results - Quick Version Earnings Call Transcript | N/A | |
| 2020-10-16 09:12 EST | News | Getinge AB reports Q3 results | N/A | |
| 2020-10-01 00:29 EST | News | Getinge's ventilator cuts time of mechanical ventilation by 35% in adult ICU patients | N/A | |
| 2020-09-26 15:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 07:51 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 11:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 15:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 19:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 07:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 23:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 17:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 15:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 20:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-17 07:13 EST | News | Getinge AB reports Q2 results | N/A | |
| 2020-07-17 07:13 EST | News | Getinge AB (GNGBF) CEO Mattias Perjos on Q2 2020 Results - Earnings Call Transcript. | N/A | |
About Getinge AB (GNGBF):
Getinge AB provides products and solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isolators, sterilizers, and logistic automation solutions; practice-oriented monitoring systems and disposables, vascular and cardiothoracic surgery solutions, anesthesia machines, beating heart surgery solutions, ceiling supply units, connected solutions, and indicators, as well as washer-disinfectors, consumables, and IT-solutions. The company also provides endovascular products; chest drain products; endoscope reprocessing; endoscopic vessel harvesting systems; critical care ventilators; extracorporeal life support or extracorporeal membrane oxygenation products; intra-aortic balloon counter pulsation therapies; operating lights; and modular room systems. In addition, it offers operating tables and accessories; operating room (OR) furniture; OR integration systems; OR management solutions; loading and distribution trolleys; patient flow management and transport solutions; sealing equipment; sterile supply management and traceability solutions; surgical perfusion components; surgical assist systems; and trays and baskets, as well as inspection and packaging and after sales consulting services. Further, the company provides professional financial advisory services to hospitals and medical facilities; and education and training services. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, Asia, and Pacific regions. The company has a partnership with Verb Surgical Inc. to develop robotic surgery solutions. Getinge AB was founded in 1904 and is headquartered in Gothenburg, Sweden.
General
- Name Getinge AB
- Symbol GNGBF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- Full Time Employees 10,818
- Last Split Factor4:1
- Last Split Date2003-11-27
- Fiscal Year EndDecember
- Web URLhttp://www.getinge.com
Valuation
- Trailing PE 16.6
- Forward PE 23.7
- Price/Sales (Trailing 12 Mt.) 2.14
- Price/Book (Most Recent Quarter) 2.94
- Enterprise Value Revenue 0.28
- Enterprise Value EBITDA 1.19
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin 11%
- Return on Assets 7%
- Return on Equity 15%
- Earnings Per Share -$0.26
- Revenue Per Share $0
- Gross Profit 14.72 billion
- Quarterly Earnings Growth 4%
Highlights
- Market Capitalization 7.51 billion
- PEG Ratio 1.74
- Book Value Per Share $7.63
Share Statistics
- Shares Outstanding 254.15 million
- Shares Float 216.44 million
- % Held by Insiders 1430%
- % Held by Institutions 58.17%
Technicals
- Beta 0.38
- 52 Week High $27.4
- 52 Week Low $15.65
- 50 Day Moving Average 25.99
- 200 Day Moving Average 22.85
Dividends
- Forward Annual Dividend Rate $0.36
- Forward Annual Dividend Yield 1.32%
- Payout Ratio 88%
- Dividend Date 2018-05-04
- ExDividend Date 2021-04-21
- Dividend Per Share $0.36
- Dividend Yield 0%
Getinge AB (GNGBF) Dividend Calendar:
GNGBF's last dividend payment was made to shareholders on May 4, 2018.
Getinge AB pays out 88% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Getinge AB (GNGBF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2020-12-31 | $N/A | $0.47 | ||
| 2020-09-30 | 2020-12-31 | $7.98 billion | $0.49 | $4.57 | -89.32% |
| 2020-06-30 | 2020-09-30 | $6.97 billion | $0.57 | $1.83 | -69.09% |
| 2020-03-31 | 2020-06-30 | $N/A | $0.19 | $1.21 | -83.92% |
| 2019-12-31 | 2020-03-31 | $8.5 billion | $0.10 | $3.76 | -97.32% |
| 2019-09-30 | 2019-12-31 | $6.24 billion | $0.35 | $0.97 | -63.42% |
| 2019-06-30 | 2019-09-30 | $6.28 billion | $0.08 | $1.11 | -93.01% |
| 2019-03-31 | 2019-06-30 | $5.55 billion | $0.04 | $0.44 | -90.75% |
| 2018-12-31 | 2019-03-31 | $7.89 billion | $0.00 | $3.22 | -99.93% |
| 2018-09-30 | 2018-12-31 | $4.44 billion | $0.30 | $0.46 | -35.8% |
| 2018-06-30 | 2018-09-30 | $4.35 billion | -$0.60 | $0.96 | -162.56% |
| 2018-03-31 | 2018-06-30 | $4.87 billion | $0.03 | $0.42 | -92.1% |
| 2017-12-31 | 2018-03-31 | $8.85 billion | -$0.14 | $4.35 | -103.11% |
| 2017-09-30 | 2017-12-31 | $7.86 billion | $0.43 | $1.55 | -72.48% |
| 2017-06-30 | 2017-09-30 | $7.24 billion | $0.06 | $1.71 | -96.51% |
| 2017-03-31 | 2017-06-30 | $6.66 billion | -$0.04 | $1.12 | -104% |
| 2016-12-31 | 2017-03-31 | $0.05 | $5.28 | -99% | |
| 2016-09-30 | 2016-10-18 | $2.44 | $1.89 | 29.1% | |
| 2016-06-30 | 2016-09-30 | -$0.04 | $1.70 | -102.48% | |
| 2016-03-31 | 2016-06-30 | $0.11 | $1.27 | -91.39% | |
| 2015-12-31 | 2016-03-31 | $0.06 | $5.30 | -98.92% | |
| 2015-09-30 | 2015-12-31 | $0.48 | $1.52 | -68.67% | |
| 2015-06-30 | 2015-09-30 | $0.09 | $1.88 | -95.4% | |
| 2015-03-31 | 2015-06-30 | $0.09 | $1.69 | -94.92% | |
| 2014-12-31 | 2015-03-31 | $0.04 | $5.41 | -99.19% | |
| 2014-09-30 | 2014-12-31 | $0.53 | $2.05 | -73.92% | |
| 2014-06-30 | 2014-09-30 | $0.21 | |||
| 2014-03-31 | 2014-06-30 | $0.25 | |||
| 2013-12-31 | 2014-03-31 | -$0.21 | |||
| 2013-09-30 | 2013-12-31 | $0.81 | |||
| 2013-06-30 | 2013-09-30 | $0.27 | |||
| 2013-03-31 | 2013-06-30 | $0.28 | |||
| 2012-12-31 | 2013-03-31 | $0.12 | |||
| 2012-09-30 | 2012-12-31 | $0.68 | |||
| 2012-06-30 | 2012-09-30 | $0.33 | |||
| 2012-03-31 | 2012-06-30 | $0.32 | |||
| 2011-12-31 | 2012-03-31 | $0.27 | |||
| 2011-09-30 | 2011-12-31 | $0.68 | |||
| 2011-06-30 | 2011-09-30 | $0.31 | |||
| 2011-03-31 | 2011-06-30 | $0.32 | |||
| 2010-12-31 | 2011-03-31 | $0.28 | |||
| 2010-09-30 | 2010-12-31 | $0.56 | |||
| 2010-06-30 | 2010-06-30 | $0.27 | |||
| 2010-03-31 | 2010-03-31 | $0.23 | |||
| 2009-12-31 | 2009-12-31 | $0.46 | |||
| 2009-09-30 | 2009-09-30 | $0.23 | |||
| 2009-06-30 | 2009-06-30 | $0.17 | |||
| 2009-03-31 | 2009-03-31 | $0.19 | |||
| 2008-12-31 | 2008-12-31 | $0.45 | |||
| 2008-09-30 | 2008-09-30 | $0.17 | |||
| 2008-06-30 | 2008-06-30 | $0.21 | |||
| 2008-03-31 | 2008-03-31 | $0.20 | |||
| 2007-12-31 | 2007-12-31 | $0.47 | |||
| 2007-09-30 | 2007-09-30 | $0.11 | |||
| 2007-06-30 | 2007-06-30 | $0.18 | |||
| 2007-03-31 | 2007-03-31 | $0.14 |
Getinge AB (GNGBF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | 207 million | 353 million | N/A | 193 million |
| Income Before Tax | N/A | 1.84 billion | 677 million | N/A | 1.37 billion |
| Selling General Administrative | N/A | 2.05 billion | 2.15 billion | N/A | 2.31 billion |
| Gross Profit | N/A | 4.13 billion | 3.46 billion | N/A | 4.06 billion |
| Ebit | N/A | 2.46 billion | 1.67 billion | N/A | 1.54 billion |
| Operating Income | N/A | 1.92 billion | 925 million | N/A | 1.54 billion |
| Income Tax Expense | 437 million | 446 million | 179 million | 150 million | 455 million |
| Total Revenue | N/A | 7.98 billion | 6.97 billion | N/A | 8.5 billion |
| Cost of Revenue | N/A | 3.85 billion | 3.51 billion | N/A | 4.44 billion |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | -171 million |
| Net Income From Continuing Operations | N/A | 1.4 billion | 497 million | N/A | 910 million |
| Net Income Applicable to Common Shares | 1.09 billion | 1.38 billion | 494 million | 271 million | 905 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | -276 million | N/A | N/A | N/A |
| Change to Liabilities | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Investing Activities | -206 million | -276 million | -1.08 billion | -261 million | -287 million |
| Net Borrowings | -1.23 billion | 2.55 billion | 576 million | -1.4 billion | -494 million |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | -1.4 billion | -514 million |
| Change to Operating Activities | -15 million | 494 million | -36 million | 286 million | 144 million |
| Change in Cash | N/A | 3.9 billion | N/A | N/A | 96 million |
| Total Cash from Operating Activities | 1.77 billion | 1.64 billion | 1.25 billion | 1.68 billion | 874 million |
| Depreciation | N/A | 744 million | N/A | 425 million | 415 million |
| Other Cash Flow from Investing Activities | 9 million | 14 million | 5 million | 96 million | 8 million |
| Change to Inventory | N/A | -546 million | N/A | 558 million | -70 million |
| Change to Account Receivables | N/A | N/A | N/A | -1.07 billion | 81 million |
| Other Cash Flow from Financing Activities | 6 million | -10 million | -3 million | N/A | -3 million |
| Change to Net Income | 284 million | 382 million | -114 million | 444 million | -31 million |
| Capital Expenditures | N/A | 284 million | N/A | 357 million | 295 million |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | 26.23 billion | 28.06 billion | N/A | 23.74 billion |
| Total Stockholder Equity | N/A | 21.52 billion | 20.79 billion | N/A | 20.5 billion |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A |
| Total Assets | N/A | 48.23 billion | 49.34 billion | N/A | 44.71 billion |
| Common Stock | 136 million | 136 million | 136 million | 136 million | 136 million |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | 14.42 billion | 13.26 billion | 12 billion | 12.01 billion | 11.61 billion |
| Other Liabilities | 11.88 billion | 12.25 billion | 12.75 billion | 12.42 billion | 11.73 billion |
| Other Assets | -1000000 | N/A | 1000000 | N/A | N/A |
| Cash | N/A | 5.72 billion | 5.85 billion | N/A | 1.25 billion |
| Total Current Liabilities | 1.45 billion | 1.94 billion | 2.04 billion | N/A | 2 billion |
| Other Stockholder Equity | -323 million | 1.34 billion | 1.87 billion | 3.33 billion | 1.97 billion |
| Property, Plant & Equipment | 3.97 billion | 4.04 billion | 4.07 billion | 4.33 billion | 4.09 billion |
| Total Current Assets | 17.43 billion | 18.96 billion | 18.93 billion | N/A | 14.49 billion |
| Long Term Investments | N/A | N/A | N/A | N/A | 1.85 billion |
| Net Tangible Assets | -1.06 billion | -2.31 billion | -3.88 billion | -4.35 billion | -3.79 billion |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | 11.09 billion | 12.37 billion | N/A | 9.11 billion |
| Inventory | 4.51 billion | 5.74 billion | 5.63 billion | N/A | 4.69 billion |
| Accounts Payable | 1.45 billion | 1.94 billion | 2.04 billion | N/A | 2 billion |
Getinge AB (GNGBF) Chart:
Getinge AB (GNGBF) News:
Below you will find a list of latest news for Getinge AB (GNGBF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Getinge AB (GNGBF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Getinge AB (GNGBF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|